This interleukin-1β has been shown to enhance the synthesis of IDO1, facilitating the conversion of tryptophan to kynurenine—a pathway that has been altered in patients with schizophrenia [38,39,40,41]. This evidence concerns the gene IDO1 and schizophrenia.